AbbVie forecasts 2026 profit above estimates on strong sales of newer immunology drugs
艾伯维(US:ABBV) Reuters·2026-02-04 20:51AbbVie forecast 2026 profit above Wall Street estimates on Wednesday after posting a fourth-quarter results beat, fueled by strong demand for newer immunology drugs Skyrizi and Rinvoq and a smaller-th... ...